Survival control of malignant lymphocytes by anti-apoptotic MCL-1

被引：35

作者：

Fernandez-Marrero, Y. ^{[1
]}

Spinner, S. ^{[2
]}

Kaufmann, T. ^{[1
]}

Jost, P. J. ^{[2
]}

机构：

[1] Univ Bern, Fac Med, Inst Pharmacol, Bern, Switzerland

[2] Tech Univ Munich, Klinikum Rechts Isar, Med Dept Hematol & Oncol 3, Ismaningerstr 22, D-81675 Munich, Germany

来源：

LEUKEMIA | 2016年 / 30卷 / 11期

基金：

瑞士国家科学基金会;

关键词：

T-CELL LYMPHOMA; BCL-2 FAMILY PROTEINS; NON-HODGKINS-LYMPHOMA; STRUCTURE-GUIDED DESIGN; GENOME-WIDE ANALYSIS; DOWN-REGULATION; IN-VITRO; B-CELLS; ANAPLASTIC LYMPHOMA; SIGNALING PATHWAY;

D O I：

10.1038/leu.2016.213

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Programmed apoptotic cell death is critical to maintain tissue homeostasis and cellular integrity in the lymphatic system. Accordingly, the evasion of apoptosis is a critical milestone for the transformation of lymphocytes on their way to becoming overt lymphomas. The anti-apoptotic BCL-2 family proteins are pivotal regulators of the mitochondrial apoptotic pathway and genetic aberrations in these genes are associated with lymphomagenesis and chemotherapeutic resistance. Pharmacological targeting of BCL-2 is highly effective in certain indolent B-cell lymphomas; however, recent evidence highlights a critical role for the BCL-2 family member MCL-1 in several lymphoma subtypes. MCL-1 is recurrently highly expressed in various kinds of cancer including non-Hodgkin's lymphoma of B-and T-cell origin. Moreover, both indolent and aggressive forms of lymphoma require MCL-1 for lymphomagenesis and for their continued survival. This review summarizes the role of MCL-1 in B-and T-cell lymphoma and discusses its potential as a therapeutic target.

引用

页码：2152 / 2159

页数：8

共 100 条

[11] MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis [J].

Craig, RW .

LEUKEMIA, 2002, 16 (04) :444-454

[12] Structural insights into the degradation of Mcl-1 induced by BH3 domains [J].

Czabotar, Peter E. ;

Lee, Erinna F. ;

van Delft, Mark F. ;

Day, Catherine L. ;

Smith, Brian J. ;

Huang, David C. S. ;

Fairlie, W. Douglas ;

Hinds, Mark G. ;

Colman, Peter M. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (15) :6217-6222

[13] Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy [J].

Czabotar, Peter E. ;

Lessene, Guillaume ;

Strasser, Andreas ;

Adams, Jerry M. .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (01) :49-63

[14] Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1 [J].

Day, Catherine L. ;

Smits, Callum ;

Fan, F. Cindy ;

Lee, Erinna F. ;

Fairlie, W. Douglas ;

Hinds, Mark G. .

JOURNAL OF MOLECULAR BIOLOGY, 2008, 380 (05) :958-971

[15]

DELGAIZO M, 2013, CANC LETT, V332, P202, DOI DOI 10.1016/J.CANLET.2011.12.021

[16] Discovery of Marinopyrrole A (Maritoclax) as a Selective Mcl-1 Antagonist that Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation [J].

Doi, Kenichiro ;

Li, Rongshi ;

Sung, Shen-Shu ;

Wu, Hongwei ;

Liu, Yan ;

Manieri, Wanda ;

Krishnegowda, Gowdahalli ;

Awwad, Andy ;

Dewey, Alden ;

Liu, Xin ;

Amin, Shantu ;

Cheng, Chunwei ;

Qin, Yong ;

Schonbrunn, Ernst ;

Daughdrill, Gary ;

Loughran, Thomas P., Jr. ;

Sebti, Said ;

Wang, Hong-Gang .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (13) :10224-10235

[17] Mcl-1 promotes survival of thymocytes by inhibition of Bak in a pathway separate from Bcl-2 [J].

Dunkle, A. ;

Dzhagalov, I. ;

He, Y-W .

CELL DEATH AND DIFFERENTIATION, 2010, 17 (06) :994-1002

[18] The anti-apoptotic Bcl-2 family member Mcl-1 promotes T lymphocyte survival at multiple stages [J].

Dzhagalov, Ivan ;

Dunkle, Alexis ;

He, You-Wen .

JOURNAL OF IMMUNOLOGY, 2008, 181 (01) :521-528

[19] The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages [J].

Dzhagalov, Ivan ;

St. John, Ashley ;

He, You-Wen .

BLOOD, 2007, 109 (04) :1620-1626

[20] Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design [J].

Friberg, Anders ;

Vigil, Dominico ;

Zhao, Bin ;

Daniels, R. Nathan ;

Burke, Jason P. ;

Garcia-Barrantes, Pedro M. ;

Camper, DeMarco ;

Chauder, Brian A. ;

Lee, Taekyu ;

Olejniczak, Edward T. ;

Fesik, Stephen W. .

JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (01) :15-30

← 1 2 3 4 5 6 7 8 9 10 →